France from insurance

한국과 정반대 정책을 시행하는 프랑스의 정책.

This is evidence of the French policy that enforces the opposite policy to Korea.

Drugs for Alzheimer's disease: finally delisted in France!

The drugs available in mid-2018 for Alzheimer's disease have only minimal and transient efficacy. They have disproportionate, serious and sometimes fatal adverse effects. It is better to avoid them and to focus instead on reorganising the patient's daily life, keeping him or her active, and providing support and help for caregivers and family members.